Skip Navigation

IID-11.1 Data Details

IID-11.1 Increase the vaccination coverage level of 1 dose of tetanus-diphtheria-acellular pertussis (Tdap) booster vaccine for adolescents by age 13 to 15 years

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

Changed Since the Healthy People 2020 Launch
Baseline (Year)
46.7 (2008)
Target-Setting Method
Maintain consistency with national programs, regulations, policies, and laws.
Number of persons aged 13 to 15 years receiving at least 1 dose of a tetanus-diphtheria-acelluar pertussis (Tdap) booster vaccine
Number of persons aged 13 to 15 years
Data Collection Frequency
Comparable Healthy People 2010 Objective
Adapted from HP2010 objective
Methodology Notes

The National Immunization Survey-Teen (NIS-Teen) collects vaccination information for adolescents aged 13–17 years in the 50 states, the District of Columbia, selected areas, and the U.S. Virgin Islands, using a random-digit–dialed sample of landline and, starting in 2011, cellular telephone numbers. Parent/guardian respondents provide vaccination and sociodemographic information on adolescents in their care. After the parent/guardian grants permission to contact their child's vaccination provider, a questionnaire is mailed to that provider to obtain a vaccination history from the medical record. Data for this measure are restricted to adolescents aged 13–15 and weighted to represent the population of adolescents age 13–15, with adjustments for households with multiple telephone lines and mixed telephone use (landline and cellular), household nonresponse, and exclusion of households without telephone service.

In 2006, the Advisory Committee on Immunization Practices (ACIP) recommended that 1) adolescents aged 11–18 years should receive a single dose of Tdap for booster immunization if they had completed the recommended childhood DTP/DTaP vaccination series and have not received Td or Tdap; 2) adolescents aged 11–18 years who received Td, but not Tdap, are encouraged to receive a single dose of Tdap to provide protection against pertussis if they have completed the recommended childhood DTP/DTaP vaccination series; and 3) vaccine providers should administer Tdap and tetravalent meningococcal conjugate vaccine (tracked in Healthy People objective to adolescents aged 11–18 years during the same visit if both vaccines are indicated and available. In 2010, ACIP approved the following additional recommendations: 1) use of Tdap regardless of interval since the last tetanus- or diphtheria-toxoid containing vaccine, 2) use of Tdap in certain adults aged 65 years and older, and 3) use of Tdap in undervaccinated children aged 7 through 10 years.

This measure tracks the proportion of adolescents aged 13–15 years receiving at least 1 dose of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) since the age of ten years.

Revision History

Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.

Description of Changes Since the Healthy People 2020 Launch

In 2014, the data source name was revised to the “National Immunization Survey (NIS) – Teen” to distinguish this survey from the “National Immunization Survey (NIS),” which samples children between the ages of 19 and 35 months. Neither the data nor the target were revised.


Additional resources about the objective.

  1. Datasets for the National Immunization Survey - Teen [online]. Atlanta (GA): National Center for Immunization and Respiratory Diseases. c2013 – [cited 2013 June 6]. Available from: